These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32469614)

  • 1. A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois.
    Ridgway JP; Farley B; Benoit JL; Frohne C; Hazra A; Pettit N; Pho M; Pursell K; Saltzman J; Schmitt J; Uvin AZ; Pitrak D; McNulty M
    AIDS Patient Care STDS; 2020 Aug; 34(8):331-335. PubMed ID: 32469614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study.
    Bhandari S; Singh A; Sharma R; Rankawat G; Banerjee S; Gupta V; Dube A; Kakkar S; Sharma S; Keswani P; Agrawal A; Tak A; Nawal CL
    J Assoc Physicians India; 2020 Jun; 68(6):13-19. PubMed ID: 32610873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
    Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients.
    Carlucci PM; Ahuja T; Petrilli C; Rajagopalan H; Jones S; Rahimian J
    J Med Microbiol; 2020 Oct; 69(10):1228-1234. PubMed ID: 32930657
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome.
    Okour M; Al-Kofahi M; Austin D
    J Pharmacokinet Pharmacodyn; 2020 Jun; 47(3):187-188. PubMed ID: 32405664
    [No Abstract]   [Full Text] [Related]  

  • 8. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease.
    Satlin MJ; Goyal P; Magleby R; Maldarelli GA; Pham K; Kondo M; Schenck EJ; Rennert H; Westblade LF; Choi JJ; Safford MM; Gulick RM
    PLoS One; 2020; 15(7):e0236778. PubMed ID: 32701969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report.
    d'Ettorre G; Recchia G; Ridolfi M; Siccardi G; Pinacchio C; Innocenti GP; Santinelli L; Frasca F; Bitossi C; Ceccarelli G; Borrazzo C; Antonelli G; Scagnolari C; Mastroianni CM
    Medicine (Baltimore); 2020 Sep; 99(36):e21803. PubMed ID: 32899009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients.
    Härter G; Spinner CD; Roider J; Bickel M; Krznaric I; Grunwald S; Schabaz F; Gillor D; Postel N; Mueller MC; Müller M; Römer K; Schewe K; Hoffmann C
    Infection; 2020 Oct; 48(5):681-686. PubMed ID: 32394344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 outbreak in Iraqi Kurdistan: The first report characterizing epidemiological, clinical, laboratory, and radiological findings of the disease.
    Merza MA; Haleem Al Mezori AA; Mohammed HM; Abdulah DM
    Diabetes Metab Syndr; 2020; 14(4):547-554. PubMed ID: 32408119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
    Bosaeed M; Mahmoud E; Hussein M; Alharbi A; Alsaedy A; Alothman A; Aljeraisy M; Alqahtani H; Nashabat M; Almutairi B; Almaghaslah M; Aldibasi O; AlJohani S; Bouchama A; Arabi Y; Alaskar A
    Trials; 2020 Oct; 21(1):904. PubMed ID: 33129363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The First Case of an HIV Patient Diagnosed with COVID-19 in Korea.
    Kim JY; Kim JM; Peck KR
    J Korean Med Sci; 2020 Oct; 35(39):e358. PubMed ID: 33045775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States.
    Byrd KM; Beckwith CG; Garland JM; Johnson JE; Aung S; Cu-Uvin S; Farmakiotis D; Flanigan T; Gillani FS; Macias-Gil R; Mileno M; Ramratnam B; Rybak NR; Sanchez M; Tashima K; Mylonakis E; Kantor R
    J Int AIDS Soc; 2020 Jul; 23(7):e25573. PubMed ID: 32657527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.
    Oldenburg CE; Doan T
    Am J Trop Med Hyg; 2020 Jun; 102(6):1154-1155. PubMed ID: 32297590
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study.
    Inciarte A; Gonzalez-Cordon A; Rojas J; Torres B; de Lazzari E; de la Mora L; Martinez-Rebollar M; Laguno M; Callau P; Gonzalez-Navarro A; Leal L; Garcia F; Mallolas J; Mosquera M; Marcos MA; Ambrosioni J; Miro JM; Martinez E; Blanco JL;
    AIDS; 2020 Oct; 34(12):1775-1780. PubMed ID: 32773471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coinfection With HIV and SARS-CoV-2 in Wuhan, China: A 12-Person Case Series.
    Hu Y; Ma J; Huang H; Vermund SH
    J Acquir Immune Defic Syndr; 2020 Sep; 85(1):1-5. PubMed ID: 32568771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.